Expert Video - How is MDS-related anemia screened and monitored?
MDS experts, Dr Rafael Bejar and Dr Casey O’Connell, explain how MDS-related anemia is screened and monitored. They explain that once a patient is identified as having anemia and has gone through the process of being diagnosed with MDS, individualized therapy will begin based on the findings of each patient. For example, patients with mild anemia may receive no intervention and might only be monitored once every few months, whereas patients with severe anemia may require blood transfusions regularly and need their blood counts checked more often.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.